Abstract
Purpose
The prostate cancer impacts on the future life of survivors. The complexity of sexual health problems in prostate cancer survivors is underestimated or often reduced to the erectile dysfunction. Especially, factors influencing sexual desire of patients have to be more explored. This study aims to describe the therapeutic management of patients with prostate cancer and assess their sexual desire 2 years after diagnosis.
Methods
This study is part of the National VICAN survey (Vie après le CANcer) implemented in France in 2012. This analysis was performed on a population of 414 men who had prostate cancer. The questionnaire dealt with several topics including socioeconomic status, treatments received, and sexual desire.
Results
Prostatectomy (42.8%), radiotherapy + hormonotherapy (17.6%), and radiotherapy alone (12.8%) were the main treatments used. 41.3% of men stated that their sexual desire was all gone since disease. The “satisfying” perceived financial situation was significantly associated to a sexual desire loss (p = 0.008). Radiotherapy + hormonotherapy treatment only is significantly associated with a loss of sexual desire (P = 0.003).
Conclusions
Two years after diagnosis, the sexual desire of prostate cancer survivors is deteriorated with the cancer experience. However, clinical characteristics do not seem to be decisive unlike a “satisfying” financial situation. Research about the impact of socio economics characteristics on sexual health should probably be engaged. Programs have to be developed in France to have personalized sexual support progressed for survivors and take spouses into consideration in this context.
Similar content being viewed by others
References
Institut National du Cancer (2014) Implication des urologues en cancérologie. Collection études et enquêtes, ouvrage collectif
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386
Carlsson S, Drevin L, Loeb S, Widmark A, Lissbrant IF, Robinson D, Johansson E, Stattin P, Fransson P (2016) Population-based study of long-term functional outcomes after prostate cancer treatment. BJU Int 117:E36–E45
Bernat JK, Wittman DA, Hawley ST, Hamstra DA, Helfand AM, Haggstrom DA et al (2016) Symptom burden and information needs in prostate cancer survivors: a case for tailored long-term survivorship care. BJU Int 118:372–378
Droupy S, Al SB, Lechevallier E, Colson MH, Giuliano F (2013) Sexuality and prostate cancer. Prog Urol 23:696–711
“La vie deux ans après un diagnostic de cancer - De l’annonce à l’après cancer”, collection Etudes et enquêtes, INCa, juin 2014
Perz J, Ussher JM, Gilbert E (2013) Constructions of sex and intimacy after cancer (2013) Q methodology study of people with cancer, their partners, and health professionals. BMC Cancer 13:270
Montgomery KA (2008) Sexual desire disorders. Psychiatry (Edgmont) 5:50–55
Colson MH, Lemaire A, Pinton P, Hamidi K, Klein P (2006) Sexual behaviors and mental perception, satisfaction and expectations of sex life in men and women in France. J Sex Med 3:121–131
Siegel T, Moul JW, Spevak M, Alvord WG, Costabile RA (2001) The development of erectile dysfunction in men treated for prostate cancer. J Urol 165:430–435
Dahn JR, Penedo FJ, Gonzalez JS, Esquiabro M, Antoni MH, Roos BA, Schneiderman N (2004) Sexual functioning and quality of life after prostate cancer treatment: considering sexual desire. Urology 63:273–277
Levine SB (2002) Reexploring the concept of sexual desire. J Sex Marital Ther 28:39–51
Levine SB (2003) The nature of sexual desire a clinician’s perspective. Arch Sex Behav 32:279–285
Carvalho J, Nobre P (2011) Biopsychosocial determinants of men's sexual desire: testing an integrative model. J Sex Med 8:754–763
Dosch A, Rochat L, Ghisletta P, Favez N, Van der Linden M (2016) Psychological factors involved in sexual desire, sexual activity, and sexual satisfaction: a multi-factorial perspective. Arch Sex Behav 45:2029–2045
Beck AM, Robinson JW, Carlson LE (2009) Sexual intimacy in heterosexual couples after prostate cancer treatment: what we know and what we still need to learn. Urol Oncol 27:137–143
Tucker SR, Speer SA, Peters S (2016) Development of an explanatory model of sexual intimacy following treatment for localised prostate cancer: a systematic review and meta-synthesis of qualitative evidence. Soc Sci Med 163:80–88
Harrington JM (2011) Implications of treatment on body image and quality of life. Semin Oncol Nurs 27:290–299
Bouhnik AD, Bendiane MK, Cortaredona S, Teyssier LS, Rey D, Berenger C et al (2015) The labour market, psychosocial outcomes and health conditions in cancer survivors: protocol for a nationwide longitudinal survey 2 and 5 years after cancer diagnosis (the VICAN survey). BMJ Open 5:e005971
Burdine JN, Felix MR, Abel AL, Wiltraut CJ, Musselman YJ (2000) The SF-12 as a population health measure: an exploratory examination of potential for application. Health Serv Res 35:885–904
Groenvold M, Klee MC, Sprangers MA, Aaronson NK (1997) Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement. J Clin Epidemiol 50:441–450
Lenormand F (2005) Le système d’information de l’assurance maladie, le SNIIR-AM et les échantillons de bénéficiaires. Courr Statistiques Insee 113–114:33–51
Berglund G, Nystedt M, Bolund C, Sjoden PO, Rutquist LE (2001) Effect of endocrine treatment on sexuality in premenopausal breast cancer patients: a prospective randomized study. J Clin Oncol 19:2788–2796
Lindau ST, Gavrilova N (2010) Sex, health, and years of sexually active life gained due to good health: evidence from two US population based cross sectional surveys of ageing. BMJ 340:c810
Bortz WM, Wallace DH, Wiley D (1999) Sexual function in 1,202 aging males: differentiating aspects. J Gerontol A Biol Sci Med Sci 54:M237–M241
Bacon CG, Mittleman MA, Kawachi I, Giovannucci E, Glasser DB, Rimm EB (2003) Sexual function in men older than 50 years of age: results from the health professionals follow-up study. Ann Intern Med 139:161–168
McCabe MP, Sharlip ID, Atalla E, Balon R, Fisher AD, Laumann E et al (2015) Definitions of sexual dysfunctions in women and men: a consensus statement from the fourth international consultation on sexual medicine. J Sex Med 2016(13):135–143
Sharp L, Carsin AE, Timmons A (2013) Associations between cancer-related financial stress and strain and psychological well-being among individuals living with cancer. Psychooncology 22:745–755
Ben Charif A, Bouhnik AD, Courbière B, Rey D, Préau M, Bendiane MK, Peretti-Watel P, Mancini J (2016) Sexual health problems in French cancer survivors 2 years after diagnosis - the national VICAN survey. J Cancer Surviv 10:600–609
Bober SL, Varela VS (2012) Sexuality in adult cancer survivors: challenges and intervention. J Clin Oncol 30:3712–3719
Ussher JM, Perz J, Gilbert E, Wong WK, Mason C, Hobbs K et al (2013) Talking about sex after cancer: a discourse analytic study of health care professional accounts of sexual communication with patients. Psychol Health 28:1370–1390
Chung E, Brock G (2013) Sexual rehabilitation and cancer survivorship: a state of art review of current literature and management strategies in male sexual dysfunction among prostate cancer survivors. J Sex Med 10(Suppl 1):102–111
Badr H, Taylor CL (2009) Sexual dysfunction and spousal communication in couples coping with prostate cancer. Psychooncology 18:735–746
Eilat-Tsanani S, Tabenkin H, Shental J, Elmalah I, Steinmetz D (2013) Patients’ perceptions of radical prostatectomy for localized prostate cancer: a qualitative study. Isr Med Assoc J 15:153–157
McConkey R (2015) Effect of erectile dysfunction following prostate cancer treatment. Nurs Stand 30:38–44
Flynn KE, Jeffery DD, Keefe FJ, Porter LS, Shelby RA, Fawzy MR, Gosselin TK, Reeve BB, Weinfurt KP (2011) Sexual functioning along the cancer continuum: focus group results from the patient-reported outcomes measurement information system (PROMIS(R)). Psychooncology 20:378–386
Corona G, Isidori AM, Aversa A, Burnett AL, Maggi M (2016) Endocrinologic control of men’s sexual desire and arousal/erection. J Sex Med 13:317–337
Corona G, Baldi E, Maggi M (2011) Androgen regulation of prostate cancer: where are we now? J Endocrinol Investig 34:232–243
Hyde MK, Zajdlewicz L, Wootten AC, Nelson CJ, Lowe A, Dunn J, Chambers SK (2016) Medical help-seeking for sexual concerns in prostate cancer survivors. Sex Med 4:e7–e17
Ben CA, Bouhnik AD, Courbiere B, Rey D, Preau M, Bendiane MK et al (2016) Patient discussion about sexual health with health care providers after cancer-a national survey. J Sex Med 13:1686–1694
Wittmann D, Northouse L, Foley S, Gilbert S, Wood DP Jr, Balon R et al (2009) The psychosocial aspects of sexual recovery after prostate cancer treatment. Int J Impot Res 21:99–106
Speer SA, Tucker SR, McPhillips R, Peters S (2017) The clinical communication and information challenges associated with the psychosexual aspects of prostate cancer treatment. Soc Sci Med 185:17–26
Flynn KE, Reese JB, Jeffery DD, Abernethy AP, Lin L, Shelby RA, Porter LS, Dombeck CB, Weinfurt KP (2012) Patient experiences with communication about sex during and after treatment for cancer. Psychooncology 21:594–601
O’Shaughnessy PK, Laws TA, Esterman AJ (2015) The prostate cancer journey: results of an online survey of men and their partners. Cancer Nurs 38:E1–E12
Acknowledgments
We thank all the members of the VICAN Group: Thomas Aparicio, Emmanuel Babin, François Beck, Daniel Benamouzig, Robert Benamouzig, Marc-Karim Bendiane, Cyril Bérenger, Dominique Bessette, Anne-Déborah Bouhnik, Philippe-Jean Bousquet, Marie-Claude Cabanel-Gicquel, Michèle Chantry, Claire Chauvet, Jacqueline Clavel, Sébastien Cortaredona, Véronique Danguy, Sarah Dauchy, Mario Di Palma, Michel Dorval, Jean-Baptiste Herbet, Laetitia Huiart, Xavier Joutard, Marianick Lambert, Anne-Gaëlle Le Corroller-Soriano, Stéphane Legleye, Julien Mancini, Jean-François Morère, Nora Moumjid-Ferdjaoui, Hermann Nabi, Alain Paraponaris, Patrick Peretti-Watel, Graziella Pourcel, Marie Préau, Frédérique Retornaze, Dominique Rey, Benoît Riandey, Laetitia Rollin, Luis Sagaon-Teyssier, Valérie Seror, Archana Singh-Manoux, Catherine Thieblemont, and Patricia Verney.
Funding
The VICAN study was funded by the French National Institute of Cancer (Institut National du Cancer, INCa) “Contrat de recherche et développement no 05-2011.”
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with ethical standards of the institutional and/or national research committee (the CCTIRS: Comité Consultatif sur le Traitement de l’Information en Matière de Recherche dans le Domaine de la Santé, study registered under no 11-143, the ISP: Institute of Public Health, study registered under no C11–63 and the CNIL: French Commission on Individual Data Protection and Public Liberties, study registered under no 911290) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the VICAN study.
Rights and permissions
About this article
Cite this article
Girodet, M., Bouhnik, AD., Mancini, J. et al. Sexual desire of French representative prostate cancer survivors 2 years after diagnosis (the VICAN survey). Support Care Cancer 27, 2517–2524 (2019). https://doi.org/10.1007/s00520-018-4536-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-018-4536-z